US budget boost for FDA and generic competition

By Dan Stanton contact

- Last updated on GMT


Related tags: Food and drug administration

An FDA advocacy group says an extra $473m of funding in the US 2019 budget request represents “an enormous vote of confidence” in the Agency.

President Trump’s 2019 Budget request​ published this week includes an extra $473m of appropriation for the US Food and Drug Administration (FDA).

Advocacy group The Alliance for a Stronger FDA described this proposal as the largest ever increase for the regulator and, according to executive director Ladd Wiley, “represents an enormous vote of confidence in FDA.”

180-day exclusivity for generic drugs

The budget also looks to tackle high drug pricing in the US through a series of measures, including by giving the FDA greater ability to bring generics to market faster by incentivizing more competition among manufacturers.

“The Budget proposes to ensure that first-to-file generic applicants who have been awarded a 180-day exclusivity period do not unreasonably and indefinitely block subsequent generics from entering the market beyond the exclusivity period,”​ the document states.

“When a first-to-file generic application is not yet approved due to deficiencies, FDA would be able to tentatively approve a subsequent generic application, which would start the 180-day exclusivity clock, rather than waiting an indefinite period for the first-to-file applicant to fix the deficiencies in its application.

“Triggering the start of the 180 day-exclusivity period for first-to-file applicants who “park” their exclusivity would speed delivery of generic drugs and provide substantial cost savings to American consumers.”

According to the budget document, this will save $118m in 2019 and $1.8bn over the next decade.

This supports draft guidance​ published last month by the FDA addressing questions around the current rules on generic drug exclusivity, commonly known as 180-day exclusivity for generic drug products.

Other requests in the budget include $5bn over the next five years to help combat the opioid epidemic, which saw around 64,000 people die from drug overdoses in 2016.

Related news

Show more

Related suppliers

Follow us


View more